focus -WSS

focus

author：focus 2025-09-07 04:06:37 - browse：577

Has PhRMA lost its fangs? Are 11th-hour changes ominous for clinical trials? And what’s next in pain medicine?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. The pharmaceutical industry, in court and in Congress, is working to water down legislation that will let Medicare negotiate certain drug prices. STAT Washington correspondent Rachel Cohrs joins us to explain the industry’s struggle to make headway — and how it factors into the 2024 election. We also discuss the latest news in the life sciences, including a twist in the future of Alnylam Pharmaceuticals, competition to Vertex Pharmaceuticals’ pain drug, and Gilead Sciences’ latest acquisition.

For more on what we cover, here’s all of Rachel’s coverage; here’s more on Vertex’s competition; here’s the news on Gilead; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

focus

WSS

Pharma companies must ensure equitable access to obesity drugs

5 takeaways from STAT's examination of Zynex Medical

Tuesday set an unofficial record for the hottest day on Earth. Wednesday may break it.

Health care court cases: Humana, Sutter, Novant

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

Climate activists disrupt London Pride march to protest corporate sponsorship

focus

focus

hotspot

The cancer drug shortage isn’t new — and neither are the solutions

Medical schools are missing the mark on artificial intelligence

At least 13 dead in Texas as scorching temps continue

Cheap, fast test for Zika and dengue could cost just $1

The cancer drug shortage isn’t new — and neither are the solutions

Calls for Trump's election interference trial to be televised part of long debate

Dobbs anniversary: the lost opportunity of abortion as health care

Lifetime voting ban for felony convictions struck down in Mississippi

Medicare details structure of new drug price negotiation program

California Joshua trees severely burned in massive wildfire

explore

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Jailed Russian opposition leader Alexey Navalny gets 19 more years in prison

US Marines prepare to be put on commercial ships to deter Iranian harassment in Strait of Hormuz

Rock icon Freddie Mercury pre

Jesse Tyler Ferguson makes friendship bracelets for Taylor Swift's Eras Tour

Pharma needs to include young adults in clinical research

focus

focus

explore

knowledge